WATCH: Axios' Future of Health Summit 2026 Tune in to Axios Live's second annual Future of Health Summit. Axios · May 13
Pharma's Direct-To-Patient Wave Hits Novartis Next The Pharmaceutical Research and Manufacturers of America (PhRMA) outlined initiatives to bolster U.S. manufacturing, ease patient costs, and improve access to medicine. Benzinga · Sep 29, 2025
Trump threatens 100% tariffs on drugmakers who aren't building U.S. plants The move raises the stakes for drug manufacturers already under pressure from the administration to lower U.S. prices. Axios · Sep 26, 2025
Australian exporters brace for immediate US tariffs on Trump’s ‘liberation day’ Government ministers still in the dark on tariffs as White House dangles hope of ‘good negotiation’ with president The Guardian - AU · Apr 1, 2025
Big pharma is taking aim at Australia’s PBS. Could Trump force us to pay more for medicines? Big pharma US wants to sell more drugs in Australia for more and its demands are now entangled with the ongoing trade tariff war The Guardian - AU · Mar 21, 2025
US Pharma Lobby Targets Australia's AU$18B PBS, Urges Trump To Impose Punitive Tariffs On March 11, a formal complaint was submitted to US Trade Representative Jamieson Greer, urging the Trump administration to take strong action against Australia's "damaging pricing policies." International Business Times · Mar 19, 2025
President-Elect Trump Hosts Pharmaceutical Ceos For Dinner At Mar-A-Lago President-elect Trump's dinner with pharmaceutical executives and healthcare appointees highlights industry collaboration and healthcare challenges. Top News · Dec 5, 2024
Biggest lobbying interests buck trend with higher 2024 spending - Roll Call Trade groups and companies responsible for this year's largest lobbying expenditures so far upped the ante in the first half of 2024. Roll Call · Aug 13, 2024
US pharma group opposing abortion pill restrictions also backs Republicans attacking drug Group advocating to preserve FDA judgment in supreme court case also gave $125,000 to Republicans opposing mifepristone The Guardian - US · Mar 8, 2024
Senators ask CEOs why their drugs cost so much more in the U.S. The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe. WEKU · Feb 8, 2024
FDA approves Florida's plan to import cheaper drugs from Canada The Food and Drug Administration's authorization of Florida's plan to import prescription medicines from Canada is a first. But the state still has hurdles to clear before imports could begin. WEKU · Jan 5, 2024
FDA greenlights Florida’s drug importation plan - Roll Call The approval makes Florida the first state to receive approval to import drugs and comes comes after three years of delay and two lawsuits. Roll Call · Jan 5, 2024
The inescapable ad campaign for a wonky drug policy debate - Roll Call A seven-figure, yearlong PhRMA ad campaign has taken a very wonky policy debate mainstream — and it's made a longtime actor a familiar face. Roll Call · Nov 17, 2023
Here are the drugs Biden is targeting first for Medicare price-lowering talks A pharmaceuticals lobbying group is criticizing the list of drugs President Joe Biden says he’s targeting for price negotiations to cut Medicare costs The Independent UK · Aug 29, 2023
The Independent UK · Aug 29, 2023 See which drugs Biden is targeting first for Medicare price-lowering talks A pharmaceuticals lobbying group is criticizing the list of drugs President Joe Biden says he’s targeting for price negotiations to cut Medicare costs
Fortune · Aug 29, 2023 Biden targets diabetes drug Jardiance, blood thinner Eliquis, and 8 others for controversial Medicare price talks. But any relief is still years away The move is expected to cut costs in a few years for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers.
Roll Call · Aug 29, 2023 HHS lists first 10 drugs subject to Medicare price negotiation - Roll Call The program is a major priority for Joe Biden, who ran for president in part on the promise to allow Medicare to negotiate drug prices.
WEKU · Jul 28, 2023 What's a fair price for a prescription drug? Medicare's about to weigh in Medicare soon will start something it hasn't done in its 58-year history: Negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.
The Independent UK · Jun 21, 2023 Drugmaker lobbying group sues over plan to negotiate Medicare drug prices A key drugmaker lobbying group has joined the legal fight against the federal government’s plan to negotiate Medicare drug prices
WEKU · Apr 14, 2023 The pharmaceutical industry urges courts to preserve access to abortion pill As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.
Los Angeles Times · Mar 24, 2023 Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.
WEKU · Feb 9, 2023 Medicare announces plan to recoup billions from drug companies Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.
The Independent UK · Aug 27, 2022 EXPLAINER: Lower prescription prices to take time in new law After decades of failed attempts, Democrats this month passed legislation that aims to reign in the soaring costs of drugs for some in the United States
WEKU · Aug 6, 2022 Congress is about to act on drug price reform. Here's what you need to know A deal on the table in Congress would help deliver on a long-time promise: to make prescription drugs more affordable. It includes a $2,000 cap on out-of-pocket expenses for Medicare patients.
Roll Call · Jul 29, 2022 Groups launch last-ditch effort against drug pricing changes - Roll Call Interest groups are spending millions in hopes of blocking legislation allowing Medicare to demand lower prices for prescription drugs.